SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Sep 1, 2016
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: Sept. 1, 2016 · CIK: 0001174940 · Accession: 0001193125-16-699643
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-213321
Referenced dates: August 31, 2016
Letter
Via Edgar United States Securities and Exchange Commission Re: Oragenics, Inc. Registration Statement on Form S-3 File No. 333-213321
Dear Mr. McCann:
Set forth below is the response of Oragenics, Inc. (the “Company”) to the Staff of the Division of Corporation Finance’s comment letter dated August 31, 2016, with respect to the Company’s Registration Statement on Form S-3 (333-213321) filed on August 25, 2016. Concurrently with this letter the Company is filing a Pre-Effective Amendment No.1 to its Registration Statement on Form S-3. For your convenience, the Staff’s comments are set forth in bold and followed by the Company’s response.
Comments
1. We note that you are registering units under the registration statement. Please have counsel revise the legality opinion to cover these units. For guidance, please see Part II.B.1.h. of Staff Legal Bulletin No. 19.
Response:
Counsel has revised its legal opinion to include the units and the Company has filed a Pre-Effective Amendment No.1 to the registration statement to include the revised legal opinion. Please see Exhibit 5.1 of the Amendment for the revised opinion.
Should you have any questions or clarifications of the matters raised in this letter please contact the undersigned at (813) 229-7600.
Sincerely,
/s/ Mark A. Catchur
Show Raw Text
CORRESP
1
filename1.htm
SEC Response Letter
Bank of America Plaza
101 East Kennedy Boulevard
Suite 2800
Tampa, Florida 33602
813.229.7600
813.229.1660 fax
www.slk-law.com
MARK A. CATCHUR
(813) 227-2264
mcatchur@slk-law.com
September 1, 2016
Via Edgar
Joseph McCann, Division of
Corporation Finance
United States Securities and Exchange Commission
100 F Street
Washington, DC 20549
Re:
Oragenics, Inc.
Registration Statement on Form
S-3
File No. 333-213321
Dear Mr. McCann:
Set forth below is the response of Oragenics, Inc. (the “Company”) to the Staff of the Division of Corporation Finance’s comment
letter dated August 31, 2016, with respect to the Company’s Registration Statement on Form S-3 (333-213321) filed on August 25, 2016. Concurrently with this letter the Company is filing a Pre-Effective Amendment No.1 to its
Registration Statement on Form S-3. For your convenience, the Staff’s comments are set forth in bold and followed by the Company’s response.
Comments
1.
We note that you are registering units under the registration statement. Please have counsel revise the legality opinion to cover these units. For guidance, please see Part II.B.1.h. of Staff Legal Bulletin
No. 19.
Response:
Counsel has revised its legal opinion to include the units and the Company has filed a Pre-Effective Amendment No.1 to the registration statement to include the revised legal opinion. Please see Exhibit 5.1 of the Amendment for
the revised opinion.
Should you have any questions or clarifications of the matters raised in this letter please contact the
undersigned at (813) 229-7600.
Sincerely,
/s/ Mark A. Catchur
Mark A. Catchur
c: Michael Sullivan, Chief Financial Officer, Oragenics, Inc.